Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200576726> ?p ?o ?g. }
Showing items 1 to 97 of
97
with 100 items per page.
- W4200576726 abstract "BACKGROUND Cefepime, a fourth-generation cephalosporin, has a known adverse effect of neurotoxicity. It occurs notably in patients with end-stage renal disease, but symptom resolution typically occurs within a median of 2 days following drug discontinuation. CASE REPORT We present a patient with end-stage renal disease on hemodialysis (TWThSat) who developed prolonged neurotoxicity lasting longer than 1 week complicated by nonconvulsive status epilepticus 2 days after cefepime discontinuation. She presented initially with a right upper-extremity arteriovenous graft infection from extended-spectrum beta-lactamase Escherichia coli, and was treated with cefepime. She eventually developed acute encephalopathy, and cefepime was discontinued. However, 2 days later, she developed seizures with worsened mental status. She was stabilized on levetiracetam and lorazepam, but developed hypotension in the Neurological Intensive Care Unit (Neuro-ICU), delaying hemodialysis. Hemodialysis was performed 6 days after cefepime discontinuation once she was stabilized, and her mental status improved 1 to 2 days after, with full improvement 20 days after admission. She was discharged on levetiracetam and meropenem. In addition, we review risk factors and symptomology of cefepime-induced neurotoxicity and discuss important management issues. CONCLUSIONS Careful attention should be paid when administering cefepime to patients with end-stage renal disease. Patients showing signs of encephalopathy should not be on cefepime any longer, and more aggressive measures may be taken, such as prompt hemodialysis, assessment of cefepime blood levels, and electroencephalogram (EEG) to monitor for signs of seizures. Prolonging hemodialysis in patients with signs of cefepime neurotoxicity can pose a danger for more serious sequelae, such as status epilepticus. Close monitoring of patients at high risk of developing adverse events from cefepime administration can ensure patient safety and well-being." @default.
- W4200576726 created "2021-12-31" @default.
- W4200576726 creator A5079956311 @default.
- W4200576726 creator A5081690282 @default.
- W4200576726 date "2021-12-08" @default.
- W4200576726 modified "2023-09-24" @default.
- W4200576726 title "Prolonged Cefepime-Induced Neurotoxicity in a Patient with End-Stage Renal Disease" @default.
- W4200576726 cites W1976567908 @default.
- W4200576726 cites W2345824798 @default.
- W4200576726 cites W2523500812 @default.
- W4200576726 cites W2596168900 @default.
- W4200576726 cites W2740977860 @default.
- W4200576726 cites W2788344645 @default.
- W4200576726 cites W2905097443 @default.
- W4200576726 cites W2911444384 @default.
- W4200576726 cites W2953583576 @default.
- W4200576726 cites W2955462198 @default.
- W4200576726 cites W2997704909 @default.
- W4200576726 cites W3004208784 @default.
- W4200576726 doi "https://doi.org/10.12659/ajcr.934083" @default.
- W4200576726 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35067669" @default.
- W4200576726 hasPublicationYear "2021" @default.
- W4200576726 type Work @default.
- W4200576726 citedByCount "4" @default.
- W4200576726 countsByYear W42005767262022 @default.
- W4200576726 countsByYear W42005767262023 @default.
- W4200576726 crossrefType "journal-article" @default.
- W4200576726 hasAuthorship W4200576726A5079956311 @default.
- W4200576726 hasAuthorship W4200576726A5081690282 @default.
- W4200576726 hasBestOaLocation W42005767262 @default.
- W4200576726 hasConcept C118552586 @default.
- W4200576726 hasConcept C126322002 @default.
- W4200576726 hasConcept C141071460 @default.
- W4200576726 hasConcept C177713679 @default.
- W4200576726 hasConcept C2776968632 @default.
- W4200576726 hasConcept C2777050379 @default.
- W4200576726 hasConcept C2777332695 @default.
- W4200576726 hasConcept C2777637488 @default.
- W4200576726 hasConcept C2778063415 @default.
- W4200576726 hasConcept C2778186239 @default.
- W4200576726 hasConcept C2778621155 @default.
- W4200576726 hasConcept C2778715236 @default.
- W4200576726 hasConcept C2779375183 @default.
- W4200576726 hasConcept C2779491297 @default.
- W4200576726 hasConcept C29730261 @default.
- W4200576726 hasConcept C3019040382 @default.
- W4200576726 hasConcept C42219234 @default.
- W4200576726 hasConcept C501593827 @default.
- W4200576726 hasConcept C523546767 @default.
- W4200576726 hasConcept C54355233 @default.
- W4200576726 hasConcept C71924100 @default.
- W4200576726 hasConcept C86803240 @default.
- W4200576726 hasConcept C89423630 @default.
- W4200576726 hasConcept C94665300 @default.
- W4200576726 hasConceptScore W4200576726C118552586 @default.
- W4200576726 hasConceptScore W4200576726C126322002 @default.
- W4200576726 hasConceptScore W4200576726C141071460 @default.
- W4200576726 hasConceptScore W4200576726C177713679 @default.
- W4200576726 hasConceptScore W4200576726C2776968632 @default.
- W4200576726 hasConceptScore W4200576726C2777050379 @default.
- W4200576726 hasConceptScore W4200576726C2777332695 @default.
- W4200576726 hasConceptScore W4200576726C2777637488 @default.
- W4200576726 hasConceptScore W4200576726C2778063415 @default.
- W4200576726 hasConceptScore W4200576726C2778186239 @default.
- W4200576726 hasConceptScore W4200576726C2778621155 @default.
- W4200576726 hasConceptScore W4200576726C2778715236 @default.
- W4200576726 hasConceptScore W4200576726C2779375183 @default.
- W4200576726 hasConceptScore W4200576726C2779491297 @default.
- W4200576726 hasConceptScore W4200576726C29730261 @default.
- W4200576726 hasConceptScore W4200576726C3019040382 @default.
- W4200576726 hasConceptScore W4200576726C42219234 @default.
- W4200576726 hasConceptScore W4200576726C501593827 @default.
- W4200576726 hasConceptScore W4200576726C523546767 @default.
- W4200576726 hasConceptScore W4200576726C54355233 @default.
- W4200576726 hasConceptScore W4200576726C71924100 @default.
- W4200576726 hasConceptScore W4200576726C86803240 @default.
- W4200576726 hasConceptScore W4200576726C89423630 @default.
- W4200576726 hasConceptScore W4200576726C94665300 @default.
- W4200576726 hasLocation W42005767261 @default.
- W4200576726 hasLocation W42005767262 @default.
- W4200576726 hasLocation W42005767263 @default.
- W4200576726 hasOpenAccess W4200576726 @default.
- W4200576726 hasPrimaryLocation W42005767261 @default.
- W4200576726 hasRelatedWork W111776911 @default.
- W4200576726 hasRelatedWork W113810927 @default.
- W4200576726 hasRelatedWork W2016203963 @default.
- W4200576726 hasRelatedWork W2099627810 @default.
- W4200576726 hasRelatedWork W2315064925 @default.
- W4200576726 hasRelatedWork W2516076952 @default.
- W4200576726 hasRelatedWork W2902246567 @default.
- W4200576726 hasRelatedWork W2994777524 @default.
- W4200576726 hasRelatedWork W40023729 @default.
- W4200576726 hasRelatedWork W4200576726 @default.
- W4200576726 hasVolume "23" @default.
- W4200576726 isParatext "false" @default.
- W4200576726 isRetracted "false" @default.
- W4200576726 workType "article" @default.